HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.

Abstract
Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.
AuthorsKrishna Pandey, V N R Das, Dharmendra Singh, Sushmita Das, C S Lal, N Verma, S Bimal, R K Topno, N A Siddiqui, R B Verma, P K Sinha, Pradeep Das
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 50 Issue 4 Pg. 1478-9 (Apr 2012) ISSN: 1098-660X [Electronic] United States
PMID22278840 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiprotozoal Agents
  • Paromomycin
Topics
  • Adult
  • Antiprotozoal Agents (administration & dosage)
  • Female
  • Humans
  • Leishmania donovani
  • Leishmaniasis, Cutaneous (complications, diagnosis, parasitology, prevention & control)
  • Leishmaniasis, Visceral (complications, drug therapy, parasitology)
  • Paromomycin (administration & dosage)
  • Secondary Prevention

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: